Despite these advancements, the precise causal relationships between specific cathepsins and chronic complications of diabetes remain inadequately defined, highlighting the need for further research to explore these associations and their potential implications for targeted therapeutic interventions. The gene discussed is CTSS; the disease is diabetes mellitus.